VYNE Therapeutics
VYNE
#9889
Rank
A$39.24 M
Marketcap
$2.58
Share price
-6.59%
Change (1 day)
-40.00%
Change (1 year)

VYNE Therapeutics (VYNE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$24.51 Million

According to VYNE Therapeutics's latest financial reports the company's total liabilities are A$24.51 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

VYNE Therapeutics - Total liabilities on balance sheet (from 2016 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$23.82 M81.36%
2023-12-31A$13.13 M-6.45%
2022-12-31A$14.04 M-44.7%
2021-12-31A$25.39 M-65.29%
2020-12-31A$73.15 M380.41%
2019-12-31A$15.22 M12.31%
2018-12-31A$13.55 M-91.46%
2017-12-31A$0.15 B60.01%
2016-12-31A$99.18 M20.75%
2015-12-31A$82.13 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$51.3 M 109.33%๐Ÿ‡บ๐Ÿ‡ธ USA